Search Clinical Trials
589,279 trials
ID
Status
Phase
Title
Sponsor
NCT07647393
Ultrasound Muscle Biomarkers as Predictors of Isometric Quadriceps Muscle Strength and Handgrip in Healthy Adults: an Observational StudyUniversity of AlcalaNot Yet Recruiting
NCT07647393Not Yet Recruiting
—
Ultrasound Muscle Biomarkers as Predictors of Isometric Quadriceps Muscle Streng...University of Alcala
NCT07648654
A Study Comparing the Hall Technique and Conventional Stainless-Steel Crowns in Carious Primary Molars : Clinical Outcomes, Anxiety, Time, and Cost-EffectivenessMTI UniversityRecruitingNot Applicable
NCT07648654Recruiting
Not Applicable
A Study Comparing the Hall Technique and Conventional Stainless-Steel Crowns in...MTI University
NCT07647562
Comparison of Outcomes of Plantar vs Groin Full-Thickness Skin Graft for Correction of Congenital Syndactyly of HandSheikh Zayed Medical CollegeCompletedNot Applicable
NCT07647562Completed
Not Applicable
Comparison of Outcomes of Plantar vs Groin Full-Thickness Skin Graft for Correct...Sheikh Zayed Medical Coll...
NCT07647068
Autologous Tumor Infiltrating Lymphocytes With Interleukin-2 for the Treatment of Locally Advanced, Recurrent or Metastatic Gastrointestinal Stromal TumorsJoal BeaneNot Yet RecruitingPhase 2
NCT07647068Not Yet Recruiting
Phase 2
Autologous Tumor Infiltrating Lymphocytes With Interleukin-2 for the Treatment o...Joal Beane
NCT07648992
Individualized Application of Anti-Thymocyte Globulin(ATG)in Unrelated Donor Hematopoietic Stem Cell TransplantationDaihong LiuRecruitingPhase 4
NCT07648992Recruiting
Phase 4
Individualized Application of Anti-Thymocyte Globulin(ATG)in Unrelated Donor Hem...Daihong Liu
NCT07649070
Phase 2 Trial of G207 + 5 Gy Radiation for Children With High-Grade GliomasM.D. Anderson Cancer CenterNot Yet RecruitingPhase 2
NCT07649070Not Yet Recruiting
Phase 2
Phase 2 Trial of G207 + 5 Gy Radiation for Children With High-Grade GliomasM.D. Anderson Cancer Cent...
NCT07647978
Development of a Predictive Score for the Risk of Infection in the Immediate Post-liver-transplant PeriodHospices Civils de LyonNot Yet Recruiting
NCT07647978Not Yet Recruiting
—
Development of a Predictive Score for the Risk of Infection in the Immediate Pos...Hospices Civils de Lyon
NCT07647783
A Single and Multiple Ascending Dose Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SYH2072 TabletsInnovStone Therapeutics LimitedRecruitingPhase 1
NCT07647783Recruiting
Phase 1
A Single and Multiple Ascending Dose Study to Evaluate Safety, Tolerability, Pha...InnovStone Therapeutics L...
NCT07648069
Tumor Neoantigen Vaccine SarVac Combined With Tumor Specific Lymphocyte Reinfusion in the Treatment of Advanced SarcomaSun Yat-sen UniversityRecruitingPhase 1
NCT07648069Recruiting
Phase 1
Tumor Neoantigen Vaccine SarVac Combined With Tumor Specific Lymphocyte Reinfusi...Sun Yat-sen University
NCT07647822
Comparison of Early Postoperative Functional Capacity and Kinesiophobia in Patients Undergoing Thoracic Surgery Via Thoracotomy or VATSHacettepe UniversityCompleted
NCT07647822Completed
—
Comparison of Early Postoperative Functional Capacity and Kinesiophobia in Patie...Hacettepe University
NCT07648758
Produce Prescription for Healthy Blood PressureTexas A&M UniversityCompletedNot Applicable
NCT07648758Completed
Not Applicable
Produce Prescription for Healthy Blood PressureTexas A&M University
NCT07647835
3 vs. 5 Days of Amoxicillin for Childhood Pneumonia: An RCTKhyber Teaching HospitalNot Yet RecruitingEarly Phase 1
NCT07647835Not Yet Recruiting
Early Phase 1
3 vs. 5 Days of Amoxicillin for Childhood Pneumonia: An RCTKhyber Teaching Hospital
NCT07646613
Study VFC202-201 is a Randomized, Double-blind, Placebo-controlled, Crossover, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of ASY202 (Dihydroergotamine Mesylate [DHE] Inhalation Powder Delivered Via a Multidose Dry Powder Inhaler) for the Acute Treatment of MigraineAspeya, Inc.RecruitingPhase 2
NCT07646613Recruiting
Phase 2
Study VFC202-201 is a Randomized, Double-blind, Placebo-controlled, Crossover, M...Aspeya, Inc.
NCT07648264
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting TherapiesCSL BehringNot Yet RecruitingPhase 3
NCT07648264Not Yet Recruiting
Phase 3
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to...CSL Behring
NCT07646678
A Study of TAK-360 in People With Narcolepsy or Idiopathic HypersomniaTakedaNot Yet RecruitingPhase 2
NCT07646678Not Yet Recruiting
Phase 2
A Study of TAK-360 in People With Narcolepsy or Idiopathic HypersomniaTakeda
NCT07648901
Scale-Up Evaluation Trial of the Diabetes Prevention Program to Improve Obesity and Cardiometabolic Health After Traumatic Brain InjuryBaylor Research InstituteNot Yet Recruiting
NCT07648901Not Yet Recruiting
—
Scale-Up Evaluation Trial of the Diabetes Prevention Program to Improve Obesity...Baylor Research Institute
NCT07646652
Alpha-synuclein Education and Disclosure in Individuals With Preclinical and Symptomatic Lewy Body DiseaseStanford UniversityNot Yet Recruiting
NCT07646652Not Yet Recruiting
—
Alpha-synuclein Education and Disclosure in Individuals With Preclinical and Sym...Stanford University
NCT07646951
Aquatic Therapy Versus Sensory Room Intervention for Sensory-Motor Function in Children With Sensory Processing DisorderMTI UniversityNot Yet RecruitingNot Applicable
NCT07646951Not Yet Recruiting
Not Applicable
Aquatic Therapy Versus Sensory Room Intervention for Sensory-Motor Function in C...MTI University
NCT07647653
Fluzoparib + Bevacizumab vs Olaparib + Bevacizumab for Maintenance Therapy in HRD-Positive Advanced Ovarian CancerShandong UniversityNot Yet RecruitingPhase 2
NCT07647653Not Yet Recruiting
Phase 2
Fluzoparib + Bevacizumab vs Olaparib + Bevacizumab for Maintenance Therapy in HR...Shandong University
Result Breakdown
Not yet recruiting11 (55%)
Recruiting6 (30%)
Completed3 (15%)
Not Specified6 (30%)
Phase 25 (25%)
not_applicable4 (20%)
Phase 12 (10%)
Phase 41 (5%)
Early Phase 11 (5%)
Phase 31 (5%)